The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: Part I

American Heart Journal

Volumn 149, Issue 6, 2005, Pages 971-976

  Armani, Annemarie ^a   Becker, Richard C ^b  

^a IntraMed   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROTEIN SUBUNIT;

ARTICLE; CARDIOVASCULAR DISEASE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; GENETIC ANALYSIS; HORMONE SUBSTITUTION; HUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SENSITIVITY AND SPECIFICITY;

EID: 20544456144     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.12.031     Document Type: Review

References (55)

1. American Heart Association Heart disease and stroke statistics-2003 update 2002 American Heart Association Dallas
2. W. Koenig, M. Sund, and M. Froelich C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 Circulation 99 1999 237 242
3. M.A. Mendall, D.P. Strachan, and B.K. Butland C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men Eur Heart J 21 2000 1584 1590
4. J.D. Curb, R.D. Abbott, and B.L. Rodriguez C-reactive protein and the future risk of thromboembolic stroke in healthy men Circulation 107 2003 2016 2020
5. P.M. Ridker, C.H. Hennekens, and J.E. Buring C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
6. P.M. Ridker, J.E. Buring, and J. Shih Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women Circulation 98 1998 731 733
7. R.P. Tracy, R.N. Lemaitre, and B.M. Psaty Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the cardiovascular health study and the rural health promotion project Arterioscler Thromb Vasc Biol 17 1997 1121 1127
8. J.J. Cao, C. Thach, and T.A. Manolio C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the cardiovascular health study Circulation 108 2003 166 170
9. P.M. Ridker, N. Rifai, and M.A. Pfeffer Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) investigators Circulation 98 1998 839 844
10. G. Liuzzo, L.M. Biasucci, and J.R. Gallimore The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina N Engl J Med 331 1994 417 424
11. B. Lindahl, H. Toss, and A. Siegbahn Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease N Engl J Med 343 2000 1139 1147
12. C. Mueller, H.J. Buettner, and J.M. Hodgson Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients Circulation 105 2002 1412 1415
13. M.N. Zairis, S.J. Manousakis, and A.S. Stefanidis C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST-segment elevation acute myocardial infarction Am Heart J 144 2002 782 789
14. F. Haverkate, S.G. Thompson, and S.D. Pyke Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study group Lancet 349 1997 462 466
15. D.A. Morrow, N. Rifai, and E.M. Antman C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in myocardial infarction J Am Coll Cardiol 31 1998 1460 1465
16. US Department of Health, Education, and Welfare Smoking and health: Report of the Advisory Committee to the Surgeon General of the Public Health Service 1964 PHS publication no 1103 Washington, DC
17. E. Durante Mangoni, L.E. Adoolfi, and M.F. Tripodi Risk factors for "major" embolic events in hospitalized patients with infective endocarditis Am Heart J 146 2003 311 316
18. N. Rifai, and P.M. Ridker Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening Clin Chem 47 2001 28 30
19. M.B. Pepys The acute phase response and C-reactive protein D.J. Weatherall J.C.G. Ledingham D.A. Warrell Oxford Textbook Of Medicine 1995 Oxford University Press London (England) 1527 1533
20. C. Gabay, and I. Kushner Acute-phase proteins and other systemic responses to inflammation N Engl J Med 340 1999 448 454
21. P.M. Ridker, M. Cushman, and M.J. Stampfer Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
22. W.J. Chwals, M. Ferandez, and A.C. Jamie Detection of postoperative sepsis in infants with the use of metabolic stress monitoring Arch Surg 129 1994 437 442
23. W.J. Chwals, R.W. Letton, and A.C. Jamie Stratification of injury severity using energy expenditure response in surgical infants J Pediatr Surg 30 1995 1161 1164
24. G.E. Curtis, C.A. McAtear, and L. Formela The effect of nutritional status on the cytokine and acute phase protein responses to elective surgery Cytokine 7 1995 380 388
25. W.S. Tillet, and T. Francis Serological reaction in pneumonia with a non-protein somatic fraction of pneumococcus J Exp Med 52 1930 561 571
26. National Library of Medicine History of Rockefeller Institute 1901-1953 1964 National Institutes of Health New York
27. S.S. Macintyre C-reactive protein Methods Enzymol 163 1988 383 399
28. A.K. Shrive, A.M. Metcalfe, and J.R. Cartwright C-reactive protein and SAP-like pentraxin are both present in Limulus polyphemus haemolymph: crystal structure of Limulus SAP J Mol Biol 290 1999 997 1008
29. M.H. Kaplan, and J.E. Volanakis Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin J Immunol 112 1974 2135 2147
30. V. Pasceri, J.T. Willerson, and E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
31. J.M. Kilpatrick, and J.E. Volanakis Molecular genetics, structure, and function of C-reactive protein Immunol Res 10 1991 43 53
32. A.J. Szalai, D.E. Briles, and J.E. Volanakis Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice J Immunol 155 1995 2557 2563
33. A.J. Szalai, J.L. VanCott, and J.R. McGhee Human C-reactive protein is protective against fatal Salmonella enterica serovar Typhimurium infection in transgenic mice Infect Immun 68 2000 5652 5656
34. D. Gershov, S. Kim, and N. Brot C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity J Exp Med 192 2000 1353 1364
35. J.E. Volanakis, and M.H. Kaplan Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide Proc Soc Exp Biol Med 136 1971 612 614
36. J.S. Pankow, A.R. Folsom, and M. Cushman Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study Atherosclerosis 154 2001 681 689
37. A.J. Szalai, M.A. McCrory, and G.S. Cooper Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene Genes Immun 3 2002 14 19
38. S. Roy, A.V. Hill, and K. Knox Research pointers: association of common genetic variant with susceptibility to invasive pneumococcal disease BMJ 324 2002 1369
39. J.K. Wolford, J.D. Gruber, and V.M. Ossowski A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians Mol Genet Metab 78 2003 136 144
40. D. Fishman, G. Faulds, and R. Jeffery The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis J Clin Invest 102 1998 1369 1376
41. C.F. Terry, V. Loukaci, and F.R. Green Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation J Biol Chem 275 2000 18138 18144
42. S.L. Ferrari, L. Ahn-Luong, and P. Garnero Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women J Clin Endocrinol Metab 88 2003 255 259
43. N.S. Jenny, R.P. Tracy, and M.S. Ogg In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease Arterioscler Thromb Vasc Biol 22 2002 2066 2071
44. M.A. Vickers, F.R. Green, and C. Terry Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein Cardiovasc Res 53 2002 1029 1034
45. N. Rifai, R.P. Tracy, and P.M. Ridker Clinical efficacy of an automated high-sensitivity C-reactive protein assay Clin Chem 45 1999 2136 2141
46. M.J. LaMonte, J.L. Durstine, and F.G. Yanowitz Cardiorespiratory fitness and C-reactive protein among a tri-ethnic sample of women Circulation 106 2002 403 406
47. P.M. Ridker, C.H. Hennekens, and N. Rifai Hormone replacement therapy and increased plasma concentration of C-reactive protein Circulation 100 1999 713 716
48. W.M. van Baal, P. Kenemans, and M.J. van der Mooren Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women Thromb Haemost 81 1999 925 928
49. X. Garcia-Moll, E. Zouridakis, and D. Cole C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men Eur Heart J 21 2000 1598 1606
50. M. Cushman, C. Legault, and E. Barrett-Connor Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study Circulation 100 1999 717 722
51. M. Visser, L.M. Bouter, and G.M. McQuillan Elevated C-reactive protein levels in overweight and obese adults JAMA 282 1999 2131 2135
52. A. Tchernof, A. Nolan, and C.K. Sites Weight loss reduces C-reactive protein levels in obese postmenopausal women Circulation 105 2002 564 569
53. S.S. Hayreh, P.A. Podhajsky, and R. Raman Giant cell arteritis: validity and reliability of various diagnostic criteria Am J Ophthalmol 123 1997 285 296
54. W.L. Roberts, R. Sedrick, and L. Moulton Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications Clin Chem 46 2000 461 468
55. W.L. Roberts, L. Moulton, and T.C. Law Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2 Clin Chem 47 2001 418 425